Common contraindications cited in the research-use community include: anyone with active or recent cancer (BPC-157 and TB-500 promote angiogenesis), people with Wilson's disease or other copper-metabolism disorders (GHK-Cu component), anyone pregnant or breastfeeding (no safety data), and athletes subject to WADA testing (BPC-157 and TB-500 are prohibited)
Chee Kay, Cheung Suceena, Alexander Heather N., Reich Haresh, Selvaskandan Hong, Zhang Jonathan, Barratt (2025) The pathogenesis of IgA nephropathy and implications for treatment Nature Reviews Nephrology 21(1):9-23
A standard 70 mg GLOW vial contains 50 mg GHK-Cu, 10 mg BPC-157, and 10 mg TB-4
MECOVA-2500 brand is one of the Top 10 Methylcobalamin Injection Brands in India which is used to treat peripheral neuropathies as well as megaloblastic anemia due to the deficiency of vitamin B12
Copper poisoning